9.70

2.41% -0.24

Adma Biologics Inc (ADMA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$9.94

Aprire:

$9.88

Volume 24 ore:

3.87M

Relative Volume:

0.79

Capitalizzazione di mercato:

$2.31B

Reddito:

$510.17M

Utile/perdita netta:

$146.93M

Rapporto P/E:

16.19

EPS:

0.599

Flusso di cassa netto:

$27.51M

1 W Prestazione:

+5.55%

1M Prestazione:

-38.72%

6M Prestazione:

-33.29%

1 anno Prestazione:

-48.07%

Intervallo 1D:

$9.6601

$10.03

Intervallo di 1 settimana:

$9.09

$10.15

Portata 52W:

$7.2101

$25.67

Adma Biologics Inc Stock (ADMA) Company Profile

Nome

Adma Biologics Inc

Settore

Healthcare (1106)

Industria

Biotechnology (623)

Telefono

(201) 478-5552

Indirizzo

C/O ADMA BIOLOGICS, INC., RAMSEY

Dipendente

647

Cinguettio

@AdmaBiologics

Prossima data di guadagno

2025-03-03

Ultimi documenti SEC

ADMA's Discussions on Twitter

Compare ADMA vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ADMA Adma Biologics Inc	9.70	2.31B	510.17M	146.93M	27.51M	0.599
VRTX Vertex Pharmaceuticals Inc	436.27	110.97B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	748.87	79.17B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	799.65	49.73B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	322.11	42.98B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	309.66	34.37B	5.36B	287.73M	924.18M	2.5229

Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-03-26	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2023-07-19	Ripresa	Raymond James	Strong Buy
2022-10-13	Iniziato	Mizuho	Buy
2021-11-11	Aggiornamento	Raymond James	Outperform → Strong Buy
2021-11-09	Iniziato	Cantor Fitzgerald	Overweight
2019-06-04	Iniziato	Jefferies	Buy
2019-04-15	Reiterato	H.C. Wainwright	Buy
2019-02-07	Ripresa	H.C. Wainwright	Buy
2017-12-11	Reiterato	Maxim Group	Buy
2017-11-14	Aggiornamento	Raymond James	Mkt Perform → Outperform
2017-01-23	Aggiornamento	Maxim Group	Hold → Buy
2016-08-01	Downgrade	Maxim Group	Buy → Hold
2016-07-25	Reiterato	Maxim Group	Buy
2015-05-13	Reiterato	Maxim Group	Buy
2014-12-08	Iniziato	Oppenheimer	Outperform
2014-12-01	Reiterato	Maxim Group	Buy

Mostra tutto

Adma Biologics Inc Borsa (ADMA) Ultime notizie

Apr 11, 2026

EV Market: Why is ADMA Biologics Inc stock going upBull Run & Momentum Based Trading Ideas - baoquankhu1.vn

Apr 11, 2026

Bronstein, Gewirtz & Grossman, LLC Encourages ADMA Biologics, Inc. (ADMA) Shareholders to Inquire about Securities Investigation - ACCESS Newswire

Apr 11, 2026

Apr 10, 2026

Gap Down: Is ADMA Biologics Inc subject to activist investor interestStock Surge & Free Growth Oriented Trading Recommendations - baoquankhu1.vn

Apr 10, 2026

ADMA Biologics (NASDAQ: ADMA) Investigated for Potential - GlobeNewswire

Apr 10, 2026

ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C. - GlobeNewswire Inc.

Apr 10, 2026

Is ADMA Poised for Margin Growth and Supply Expansion in 2026? - TradingView

Apr 10, 2026

A Look At ADMA Biologics (ADMA) Valuation After Short Seller Allegations And Legal Investigations - Sahm

Apr 10, 2026

ADMA Biologics Faces Securities Fraud Probe Over Channel Stuffing Claims - National Today

Apr 10, 2026

ADMA Biologics Faces Securities Fraud Investigation Over Alleged Channel Stuffing - National Today

Apr 10, 2026

Growth Value: Whats the fair value of ADMA Biologics Inc stock2026 Recap & Accurate Intraday Trade Tips - baoquankhu1.vn

Apr 10, 2026

Apr 09, 2026

Growth Value: Is ADMA Biologics Inc attractive for institutional investors2026 Price Swings & Advanced Swing Trade Entry Plans - baoquankhu1.vn

Apr 09, 2026

Adma Biologics (ADMA) Laps the Stock Market: Here's Why - Yahoo Finance

Apr 09, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc.ADMA - PR Newswire

Apr 09, 2026

ADMA Fraud Notice: ADMA Biologics Investors are Notified the Company is being Investigated for Securities Fraud after 29% Stock Drop — BFA Law - Business Wire

Apr 09, 2026

Apr 08, 2026

Advantage Alpha Capital Partners LP's ADMA Biologics Inc(ADMA) Holding History - GuruFocus

Apr 08, 2026

Bragar Eagel & Squire, P.C. Urges ADMA Biologics, Inc. - GlobeNewswire

Apr 08, 2026

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ADMA Biologics, Inc. (ADMA) And Encourages Shareholders to Reach Out - ACCESS Newswire

Apr 08, 2026

ADMA Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 08, 2026

Lowey Dannenberg, P.C. is Investigating ADMA Biologics (NASDAQ: ADMA) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm - The Globe and Mail

Apr 08, 2026

ADMA Investor Announcement: ADMA Biologics Investigated - GlobeNewswire

Apr 08, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ADMA Biologics, Inc. (ADMA) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Apr 08, 2026

Apr 07, 2026

ADMA Biologics Under Investigation for Securities Violations - Intellectia AI

Apr 07, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA ... - Bluefield Daily Telegraph

Apr 07, 2026

ADMA Biologics: The Short Report Is The Noise, Not The Signal (NASDAQ:ADMA) - Seeking Alpha

Apr 07, 2026

Aberdeen Group Reduces ADMA Biologics Stake - National Today

Apr 07, 2026

ADMA Biologics gains after refuting short seller claims - MSN

Apr 07, 2026